Silverback Asset Management’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$571K Buy
+15,000
New +$632K 0.04% 60

Other funds holding DFTX

Silverback Asset Management's DFTX Position: Q3 2026 in Review

Silverback Asset Management opened a new position in Definium Therapeutics (DFTX) in Q3 2026: 15,000 shares worth $571K. The stake represents 0.04% of the portfolio and ranks #60 among its holdings.

354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Silverback Asset Management held 15,000 shares of Definium Therapeutics worth $571K as of Q3 2026.
  • Definium Therapeutics was a new Silverback Asset Management position in Q3 2026.
  • Definium Therapeutics made up 0.04% of Silverback Asset Management's portfolio in Q3 2026, its #60 holding.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Silverback Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.